|
Covid-19 Vaccine and Pills Will Push Pfizer’s Revenue Above $100B Next Year, Analyst Says
By Josh Nathan-Kazis
Nov. 23, 2021 9:13 am ET
Order Reprints
Print Article
Pfizer‘s revenue will top $100 billion next year, boosted by sales of its Covid-19 vaccine and its new Covid-19 antiviral pill, according to SVB Leerink.
That’s up from $41.9 billion in 2020, and the FactSet consensus estimate of $80.7 billion in 2021.
Analyst Dr. Geoffrey Porges wrote in a note out early Tuesday that he expects Pfizer |
|